Results 31 to 40 of about 330,389 (214)

Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia

Journal of Hematology & Oncology, 2023
Background The treatment landscape for chronic lymphocytic leukemia (CLL) continues to undergo considerable evolution. Optimal selection of initial therapy from multiple effective options provides a major challenge for clinicians, who need to consider ...
Rory Bennett, Mary Ann Anderson, John F. Seymour   +2 more
doaj   +1 more source

Drug-induced arrhythmias

Медицинский совет, 2021
The article provides a scientific review based on the proceedings of the 2020 American Heart Association consensus on drugs that may cause arrhythmias on a risk-sensitive basis and a guidance on strategies for monitoring, prevention methods and ...
M. V. Leonova
doaj   +1 more source

Choosing a class IC antiarrhythmic drug for the treatment of patients without structural heart disease: clinical advantages of the most common agents (literature review)

Сучасні медичні технології
Aim: to analyze the pharmacological features and updated evidence-based medicine data of Class IC antiarrhythmic drug (AAD) ethacizine compared to propafenone to optimize the choice of treatment for cardiac arrhythmias in patients without structural ...
N. M. Sydorova, M. Yu. Kolesnyk
doaj   +1 more source

Diagnostic lacunae and implications of an automated implantable cardioverter defibrillator implantation in a child with type 3 Long QT (LQT3) syndrome

Annals of Cardiac Anaesthesia, 2022
A diagnosis of congenital long QT interval syndrome based on history and electrocardiogram was made in a child in the absence of readily available genetic testing.
Madan M Maddali, Pranav S Kandachar, Ismail A Al-Abri, Mohammed I Al-Yamani   +3 more
doaj   +1 more source

Ryanodine receptor in heart failure: potential therapeutic sites. [PDF]

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2010
Heart failure (HF) is one of the most important contributors to morbidity and mortality from cardiac diseases. Ca2+ handling abnormalities play an important role in the development of HF.
Guy Vasort
doaj  

Left Atrium Sphericity and Catheter Ablation Outcome in Atrial Fibrillation Patients: A Single-center Cross-sectional Study

Research in Cardiovascular Medicine
Introduction: Catheter ablation is becoming an increasingly utilized treatment option for atrial fibrillation (AF) due to its proven efficacy. This study aims to examine the correlation between changes in left atrium (LA) sphericity and the outcomes of ...
Parisa Ahmadi, Majid Haghjoo, Danial Farmani, Amir Askarinejad, Sara Adimi, Mona Heidarali, Hamideh Khesali   +6 more
doaj   +1 more source

Estudo transversal das estratégias de tratamento clínico na fibrilação atrial Estudio transversal de las estrategias de tratamiento clínico en la fibrilación atrial Cross-sectional study of treatment strategies on atrial fibrillation

Arquivos Brasileiros de Cardiologia, 2012
FUNDAMENTO: A despeito de elevada prevalência e importância clínica da Fibrilação Atrial (FA), não existem até o momento publicações brasileiras informando o perfil clínico e a estratégia de tratamento (controle de ritmo vs.
Lucas Hollanda Oliveira, Fabrício Bonnoto Mallmann, Fábio Nardo Botelho, Luiz Carlos Paul, Marcio Gianotto, Rafael de Biase Abt, Nilton José Carneiro Silva, Christian Moreno Luize, Fernando Lopes Nogueira, Ricardo Sobral Carvalho, Angelo Amato Vincenzo de Paola, Claudio Cirenza   +11 more
doaj  

Ellagic acid improved arrhythmias induced by CaCL2 in the rat stress model [PDF]

Avicenna Journal of Phytomedicine, 2015
Objective: In ventricular arrhythmias, due to their free radical scavenging action, antioxidant agents are usually used in the treatment of cardiovascular disease.
Mahin Dianat, Negin Amini, Mohammad Badavi, Yaghoub Farbood   +3 more
doaj  

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Italian Journal of Medicine, 2016
Atrial fibrillation (AF) is the most common cardiac arrhythmia. This analysis aimed to determine the sex-gender differences in patients with AF enrolled in the observational AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study.
Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators   +11 more
doaj   +1 more source

In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding

Frontiers in Pharmacology, 2017
Current pharmacological therapy against atrial fibrillation (AF), the most common cardiac arrhythmia, is limited by moderate efficacy and adverse side effects including ventricular proarrhythmia and organ toxicity.
Nicholas Ellinwood, Dobromir Dobrev, Stefano Morotti, Eleonora Grandi   +3 more
doaj   +1 more source